Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol Add-on to Lisinopril or Losartan in Hypertension
NCT00734630Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Aug 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Nebivolol with Placebo (2 arms). Primary endpoint: Mean Seated Trough Cuff Systolic Blood Pressure at 12 weeks. Started Aug 2008; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00734630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734630.